Arctic Bioscience (Norway) Market Value
ABS Stock | NOK 4.76 0.58 13.88% |
Symbol | Arctic |
Arctic Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arctic Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arctic Bioscience.
03/12/2023 |
| 03/01/2025 |
If you would invest 0.00 in Arctic Bioscience on March 12, 2023 and sell it all today you would earn a total of 0.00 from holding Arctic Bioscience AS or generate 0.0% return on investment in Arctic Bioscience over 720 days. Arctic Bioscience is related to or competes with Airthings ASA, Aega ASA, Huddly AS, and Bergenbio ASA. Arctic Bioscience AS, a biotechnology company, provides nutraceutical and pharmaceutical products More
Arctic Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arctic Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arctic Bioscience AS upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 4.46 | |||
Information Ratio | 0.2089 | |||
Maximum Drawdown | 39.43 | |||
Value At Risk | (6.61) | |||
Potential Upside | 17.14 |
Arctic Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arctic Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arctic Bioscience's standard deviation. In reality, there are many statistical measures that can use Arctic Bioscience historical prices to predict the future Arctic Bioscience's volatility.Risk Adjusted Performance | 0.1616 | |||
Jensen Alpha | 1.52 | |||
Total Risk Alpha | 1.81 | |||
Sortino Ratio | 0.358 | |||
Treynor Ratio | (0.71) |
Arctic Bioscience Backtested Returns
Arctic Bioscience is dangerous given 3 months investment horizon. Arctic Bioscience secures Sharpe Ratio (or Efficiency) of 0.22, which signifies that the company had a 0.22 % return per unit of standard deviation over the last 3 months. We are able to interpolate and collect twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.79% are justified by taking the suggested risk. Use Arctic Bioscience risk adjusted performance of 0.1616, and Mean Deviation of 5.28 to evaluate company specific risk that cannot be diversified away. Arctic Bioscience holds a performance score of 17 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.22, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Arctic Bioscience are expected to decrease by larger amounts. On the other hand, during market turmoil, Arctic Bioscience is expected to outperform it. Use Arctic Bioscience sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to analyze future returns on Arctic Bioscience.
Auto-correlation | 0.19 |
Very weak predictability
Arctic Bioscience AS has very weak predictability. Overlapping area represents the amount of predictability between Arctic Bioscience time series from 12th of March 2023 to 6th of March 2024 and 6th of March 2024 to 1st of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arctic Bioscience price movement. The serial correlation of 0.19 indicates that over 19.0% of current Arctic Bioscience price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.19 | |
Spearman Rank Test | -0.03 | |
Residual Average | 0.0 | |
Price Variance | 19.31 |
Arctic Bioscience lagged returns against current returns
Autocorrelation, which is Arctic Bioscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Arctic Bioscience's stock expected returns. We can calculate the autocorrelation of Arctic Bioscience returns to help us make a trade decision. For example, suppose you find that Arctic Bioscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Arctic Bioscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Arctic Bioscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Arctic Bioscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Arctic Bioscience stock over time.
Current vs Lagged Prices |
Timeline |
Arctic Bioscience Lagged Returns
When evaluating Arctic Bioscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Arctic Bioscience stock have on its future price. Arctic Bioscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Arctic Bioscience autocorrelation shows the relationship between Arctic Bioscience stock current value and its past values and can show if there is a momentum factor associated with investing in Arctic Bioscience AS.
Regressed Prices |
Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Arctic Stock
Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.